Assessment report Anatabine, applicant Rock Creek Pharmaceuticals LLC
A report on the initial assessment of anatabine by the company Rock Creek Pharmaceuticals.
The application concerns the substance anatabine for use as a food supplement. The VNV Committee recommends refusal of the application for approval of the product as a novel food.
This report describes a so-called ‘initial assessment’ according to the European approval procedure for novel foods, as governed by European Regulation 258/97.
The Novel Foods Unit sent this assessment report to the Minister of Health, Welfare and Sport on 25 June 2015.